IMV

-$0.01 (-0.57%) As of 7:20 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMV and other ETFs, options, and stocks.

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company that engages in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company leverages its delivery platform (DPX) that programs immune cells directly within the human body to produce robust and sustained target killing capabilities.

CEO

Frederic Ors

Employees

—

Headquarters

Dartmouth, Nova Scotia

Founded

2007

IMV Key Statistics

Market Cap

157.40M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

10.15M

High Today

$1.80

Low Today

$1.72

Open Price

$1.75

Volume

729.19K

52 Week High

$5.73

52 Week Low

$1.31

Analyst Ratings

67%

of 6 ratings

Buy

66.7%

Hold

33.3%

Sell

IMV Earnings

-$0.19

-$0.13

-$0.06

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 8, Pre-Market